Listen

Promoting a Culture of Safety with the Use of Gadolinium-based Contrast Agents: What Pharmacists Need to Know

Gadolinium-based contrast agents (GBCAs) are widely used in health systems. Although generally considered safe, pharmacists must still take into consideration the characteristics of each agent when making formulary decisions. This educational activity will review available GBCAs with a focus on the efficacy and safety of each agent. Commercially available GBCAs will also be compared in terms of their relaxivity, stability, dosing volume, and exposure. The education will also incorporate patient-specific clinical characteristics to consider in the safe and efficacious selection of GBCAs.

Tuesday, July 23
12 - 1 p.m. ET

Webinar Registration

Speakers

Christopher J. deHoll, PharmD, MS, BCSCP
Clinical Sterile Products Pharmacist
Duke University Hospital
Durham, North Carolina

Christopher J. deHoll, PharmD, MS, BCSCP is a Clinical Sterile Products Pharmacist at the Duke University Medical Center. Dr. deHoll earned his Doctor of Pharmacy degree from the Medical University of South Carolina (MUSC) in Charleston, SC. He served as a Board-Certified Nuclear Pharmacist (BCNP) from 2011 to 2018. In 2021, he became a Board-Certified Sterile Compounding Pharmacist (BCSCP). In 2023, he graduated from the University of Florida with a master’s in science in Clinical Toxicology. He is currently pursuing a second master’s in science in Health-Systems Pharmacy Administration and Leadership (HS-PAL) from the UNC Eshelman School of Pharmacy.

Ari Goldberg, MD, PhD
Medical Director, MRI
Loyola University Health System
Maywood, Illinois

Ari Goldberg, MD, PhD is the current Director of Chest and Abdominal Imaging as well as Medical Director of MRI, at Loyola University Health System and recent past president of the Chicago Radiologic Society. He received his MD, PhD (Biophysics) degrees from the University of Pennsylvania in 2004 and completed a diagnostic radiology residency and cardiothoracic imaging fellowship at the Hospital of University of Pennsylvania (2005-2010). As an academician, he has research interests and partnerships, including publications, in development of novel MRI and CT techniques, Artificial Intelligence (including workflow optimization, cancer detection, and COVID classifiers), and contrast material safety and optimization. Dr Goldberg has particular clinical interests in cardiovascular disease, infection, and chronic lung diseases.

Target Audience

This activity was planned to meet the educational needs of pharmacists who practice in hospitals and health systems, who care for or are interested in the care of patients requiring contrast agents.

Learning Objectives

Review key considerations regarding efficacy and safety when selecting a gadolinium-based contrast agent (GBCA).
Compare commercially available GBCAs with respect to relaxivity, stability, dosing volume, and exposure.
Incorporate patient-specific clinical characteristics and dosing considerations in the safe and efficacious selection of GBCAs.

Agenda

12 p.m. - 12:05 p.m. – Welcome and Introductions
Christopher J. deHoll
12:05 p.m. - 12:25 p.m. – Assessing the GBCAs: Focus on Efficacy and Safety
Ari Goldberg and Christopher J. deHoll
12:25 p.m. - 12:50 p.m. – Incorporate patient-specific clinical characteristics and dosing considerations in the safe and efficacious selection of GBCAs
All Faculty
12:50 p.m. - 1 p.m. – Faculty Discussion, Questions and Answers
All Faculty

Accredited for CPE

ACPE #: 0204-0000-24-405-L99-P
CE Credit: 1.0 contact hours (0.1 CEUs)
Activity Type: Application-based
Activity Fee: No charge

To Claim CE for the webinar, enter the CE code announced during the activity and complete the evaluation.